Hypoxia: Molecules, Mechanisms and Disease
Organizer(s): José López-Barneo, Sarah R. Walmsley, Hesham A. Sadek and Jacques PouysségurDate: January 19 - 23, 2020
Location: Keystone Resort, Keystone, CO, USA
For important information on the coronavirus, please click here
Hypoxia research reflects a dynamic and rapidly expanding field with growing implications ranging from basic molecular biology to medicine. Changes in cellular oxygen availability secondary to environmental challenges or diseases, trigger a broad array of adaptive responses that can be rapid (seconds) or more protracted (weeks to months). The molecules and mechanisms involved in these versatile hypoxia signaling pathways are fundamental to the pathogenesis of highly prevalent medical conditions, among which are respiratory depression, hypertension, tumor progression and inflammation. Moreover, oxygen regulates cellular processes, which are essential to cell reprogramming, development and tissue/organ regeneration. In this conference on Hypoxia, the tenth in the series of Keystone Symposia, experts from basic, clinical and industrial backgrounds will gather to update the status of the field, to discuss the most relevant discoveries and their applications, and to envision the conceptual and technological trends for upcoming years. The conference is designed to provide a broad coverage of the hypoxia field, with emphasis in translational strategies and perspectives. It will also promote multidisciplinary collaborations between scientists from different research backgrounds and the interaction between new graduate students and postdocs with leaders in this discipline.
Scholarship Deadline: September 25 2019
Discounted Abstract Deadline: September 25 2019
Abstract Deadline: October 16 2019
Discounted Registration Deadline: November 19 2019
Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email email@example.com if you are interested.
We gratefully acknowledge additional support for this conference from:
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
Merck Research Laboratories
We gratefully acknowledge the generous grant for this conference provided by:National Heart, Lung, and Blood Institute (NHLBI)
Grant No. 1R13HL149442-01
Funding for this conference was made possible (in part) by 1R13HL149442-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.